Table 2.
LEDS | CSI | PSS | MADRAS | MDE | ACTIVE | AVOID | T1 ADH | T2 ADH | |
---|---|---|---|---|---|---|---|---|---|
LEDS | 0.45** | 0.28** | 0.33** | 0.28** | 0.17 | 0.21* | −0.11 | −0.26* | |
CSI | 0.25* | 0.43** | 0.27* | 0.18 | 0.24* | −0.15 | −0.14 | ||
PSS | 0.23* | 0.02 | 0.02 | 0.03 | 0.14 | −0.06 | |||
MADRAS | 0.60** | 0.01 | 0.54** | −0.36** | −0.22* | ||||
MDE | −0.15 | 0.33* | −0.31* | −0.19 | |||||
ACTIVE | 0.04 | −0.05 | −0.22* | ||||||
AVOID | −0.20 | −0.06 | |||||||
T1 ADH | 0.48** | ||||||||
T2 ADH |
P < 0.05;
P < 0.01
LEDS Cumulative threat associated with acute life events, as measured by Life Events and Difficulties Schedule, CSI Chronic stress, as measured by Chronic Strain Interview, PSS perceived stress, as measured by Perceived Stress Scale-4 item measure, MADRAS Clinician-assessed depression, as measured by the Montgomery-Asberg Depression Rating Scale, MDE Presence/absence of current Major Depressive Episode, ACTIVE active coping style, as measured by Brief COPE, AVOIDANT avoidant coping style, as measured by Brief COPE, T1 ADH time 1 treatment adherence, T2 ADH time 2 treatment adherence